StreetInsider.com News Articles

Form 4 AETHLON MEDICAL INC For: Oct 08 Filed by: LAROSA STEVEN P

Thu, 15 Oct 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20261015/27193448.html

Form 4 AETHLON MEDICAL INC For: Sep 30 Filed by: Shah Chetan

Thu, 15 Oct 2026 12:50:00 -0400

si-local-file:///var/storage/secattach/20261015/27192402.html

Form 4/A AETHLON MEDICAL INC For: Apr 17 Filed by: Rossetti Angela

Thu, 15 Oct 2026 12:50:00 -0400

si-local-file:///var/storage/secattach/20261015/27192399.html

Form 4 AETHLON MEDICAL INC For: Sep 30 Filed by: Gikakis Nicolas

Thu, 15 Oct 2026 12:49:00 -0400

si-local-file:///var/storage/secattach/20261015/27192398.html

Form 4 AETHLON MEDICAL INC For: Sep 30 Filed by: BROENNIMAN EDWARD G

Thu, 15 Oct 2026 12:49:00 -0400

si-local-file:///var/storage/secattach/20261015/27192397.html

Form 4 AETHLON MEDICAL INC For: Oct 08 Filed by: FRAKES JAMES B

Tue, 13 Oct 2026 21:14:00 -0400

si-local-file:///var/storage/secattach/20261013/27182379.html

Form SCHEDULE 13G AETHLON MEDICAL INC Filed by: JANE STREET GROUP, LLC

Tue, 13 Oct 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20261013/27181617.html

Form 8-K AETHLON MEDICAL INC For: Oct 07

Fri, 09 Oct 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20261009/27171704.html

Form 8-K/A AETHLON MEDICAL INC For: Oct 01

Mon, 05 Oct 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20261005/27148878.html

Form 8-K AETHLON MEDICAL INC For: Oct 01

Thu, 01 Oct 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20261001/27137320.html

H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)

Fri, 18 Sep 2026 06:48:04 -0400

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Neutral rating and $1.50 price target on Aethlon Medical (NASDAQ: AEMD).

The analyst commented: "On September 17, 2026, Aethlon announced a definitive all-stock merger agreement with North Immunology (private), an immune and inflammatory disease (I&I) company developing bispecific antibodies. Concurrent with the merger agreement, North Immunology plans to raise $180M in aggregate funds through equity offering, of which approximately $146M is cash and the remainder is in the form of convertible notes. Management expects the financing to fund the combined company’s planned operations into 2H28. The combined company will be led by North Immunology

Four High-Impact Small Caps Enter the Spotlight

Thu, 17 Sep 2026 11:37:04 -0400

DENVER, Sept. 17, 2026 (GLOBE NEWSWIRE) -- The small-cap market is delivering a mix of catalysts, with the following companies in particular putting substantial new developments in front of investors: Aethlon Medical (NASDAQ:AEMD), NeOnc Technologies Holdings (NASDAQ:NTHI), bioAffinity Technologies (NASDAQ:BIAF), and Turbo Energy (NASDAQ:TURB).